| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $56.10 | $561k | | 06/15/2023 |
| 05/26/2023 | Shattuck Labs, Inc. | STTK | Grant | Stock Option (Right to Buy) | 40.3k | $2.72 | $109.5k | | 05/26/2023 |
| 01/04/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 2.1k | $39.16 | $82.5k | | 01/04/2023 |
| 06/16/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 9.9k | $31.36 | $311.9k | | 06/16/2022 |
| 06/08/2022 | Shattuck Labs, Inc. | STTK | Grant | Stock Option (Right to Buy) | 40.3k | $4.32 | $173.9k | | 06/08/2022 |
| 05/05/2022 | Sage Therapeutics, Inc. | SAGE | Purchase | Common Stock | 8k | $31.45 | $251.6k | | 05/05/2022 |
| 04/26/2022 | Shattuck Labs, Inc. | STTK | Purchase | Common Stock | 28.3k | $3.63 | $102.8k | | 04/26/2022 |
| 04/22/2022 | Shattuck Labs, Inc. | STTK | Purchase | Common Stock | 234 | $3.67 | $858.8 | | 04/21/2022 |
| 04/21/2022 | Shattuck Labs, Inc. | STTK | Purchase | Common Stock | 26k | $3.69 | $96.1k | | 04/21/2022 |
| 01/04/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 1.6k | $42.21 | $69.1k | | 01/04/2022 |
| 06/19/2021 | Shattuck Labs, Inc. | STTK | Grant | Stock Option (Right to Buy) | 3.4k | $29.34 | $100.8k | | 06/19/2021 |
| 06/10/2021 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $76.09 | $760.9k | | 06/10/2021 |
| 12/22/2020 | Shattuck Labs, Inc. | STTK | Grant | Stock Option (Right to Buy) | 1.3k | $53.02 | $68.2k | | 12/22/2020 |
| 07/06/2020 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | Grant | | 81k | $7.91 | $640.7k | | 07/06/2020 |
| 06/09/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $36.47 | $364.7k | | 06/09/2020 |
| 02/26/2020 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 10k | $51.04 | $510.4k | | 02/26/2020 |
| 01/03/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 976 | $73.53 | $71.8k | | 01/03/2020 |
| 06/05/2019 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $177.41 | $1.8M | | 06/05/2019 |
| 03/04/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 9.3k | $103.65 | $961.9k | | 03/04/2019 |
| 03/04/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Exercise | Stock Option (Right to Buy) | 9.3k | $36.61 | $339.7k | | 03/04/2019 |
| 02/28/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 5k | $102.54 | $512.7k | | 02/28/2019 |
| 02/12/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Exercise | Stock Option (Right to Buy) | 3.7k | $25.58 | $95.4k | | 02/11/2019 |
| 02/12/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Exercise | Stock Option (Right to Buy) | 7.5k | $29.02 | $217.6k | | 02/11/2019 |
| 02/12/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 11.2k | $90.07 | $1M | | 02/11/2019 |
| 02/11/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Exercise | Stock Option (Right to Buy) | 2.3k | $25.58 | $58.1k | | 02/11/2019 |
| 02/11/2019 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 2.3k | $90.03 | $204.6k | | 02/11/2019 |
| 01/22/2019 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 20k | $137.29 | $2.7M | | 01/22/2019 |
| 02/28/2018 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 7.5k | $78.62 | $589.6k | | 02/28/2018 |